170 related articles for article (PubMed ID: 38238426)
1. Redox signalling regulates breast cancer metastasis via phenotypic and metabolic reprogramming due to p63 activation by HIF1α.
Ren Z; Dharmaratne M; Liang H; Benard O; Morales-Gallego M; Suyama K; Kumar V; Fard AT; Kulkarni AS; Prystowsky M; Mar JC; Norton L; Hazan RB
Br J Cancer; 2024 Apr; 130(6):908-924. PubMed ID: 38238426
[TBL] [Abstract][Full Text] [Related]
2. Redox signaling by glutathione peroxidase 2 links vascular modulation to metabolic plasticity of breast cancer.
Ren Z; Liang H; Galbo PM; Dharmaratne M; Kulkarni AS; Fard AT; Aoun ML; Martinez-Lopez N; Suyama K; Benard O; Zheng W; Liu Y; Albanese J; Zheng D; Mar JC; Singh R; Prystowsky MB; Norton L; Hazan RB
Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35193955
[TBL] [Abstract][Full Text] [Related]
3. Quantifying the Patterns of Metabolic Plasticity and Heterogeneity along the Epithelial-Hybrid-Mesenchymal Spectrum in Cancer.
Muralidharan S; Sahoo S; Saha A; Chandran S; Majumdar SS; Mandal S; Levine H; Jolly MK
Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204797
[TBL] [Abstract][Full Text] [Related]
4. Hybrid Stem Cell States: Insights Into the Relationship Between Mammary Development and Breast Cancer Using Single-Cell Transcriptomics.
Thong T; Wang Y; Brooks MD; Lee CT; Scott C; Balzano L; Wicha MS; Colacino JA
Front Cell Dev Biol; 2020; 8():288. PubMed ID: 32457901
[TBL] [Abstract][Full Text] [Related]
5. MLL3 loss drives metastasis by promoting a hybrid epithelial-mesenchymal transition state.
Cui J; Zhang C; Lee JE; Bartholdy BA; Yang D; Liu Y; Erler P; Galbo PM; Hodge DQ; Huangfu D; Zheng D; Ge K; Guo W
Nat Cell Biol; 2023 Jan; 25(1):145-158. PubMed ID: 36604594
[TBL] [Abstract][Full Text] [Related]
6. Numb prevents a complete epithelial-mesenchymal transition by modulating Notch signalling.
Bocci F; Jolly MK; Tripathi SC; Aguilar M; Hanash SM; Levine H; Onuchic JN
J R Soc Interface; 2017 Nov; 14(136):. PubMed ID: 29187638
[TBL] [Abstract][Full Text] [Related]
7. GPX2 promotes EMT and metastasis in non-small cell lung cancer by activating PI3K/AKT/mTOR/Snail signaling axis.
Peng F; Xu Q; Jing X; Chi X; Zhang Z; Meng X; Liu X; Yan J; Liu X; Shao S
FASEB Bioadv; 2023 Jun; 5(6):233-250. PubMed ID: 37287867
[TBL] [Abstract][Full Text] [Related]
8. Breast tumor cell-specific knockout of
Xu Y; Lee DK; Feng Z; Xu Y; Bu W; Li Y; Liao L; Xu J
Proc Natl Acad Sci U S A; 2017 Oct; 114(43):11494-11499. PubMed ID: 29073077
[TBL] [Abstract][Full Text] [Related]
9. GPX2 silencing relieves epithelial-mesenchymal transition, invasion, and metastasis in pancreatic cancer by downregulating Wnt pathway.
Li F; Dai L; Niu J
J Cell Physiol; 2020 Nov; 235(11):7780-7790. PubMed ID: 31774184
[TBL] [Abstract][Full Text] [Related]
10. GPX2 suppression of H
Wang Y; Cao P; Alshwmi M; Jiang N; Xiao Z; Jiang F; Gu J; Wang X; Sun X; Li S
Onco Targets Ther; 2019; 12():6639-6651. PubMed ID: 31695405
[TBL] [Abstract][Full Text] [Related]
11. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP
J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971
[TBL] [Abstract][Full Text] [Related]
12. Loss of function of GATA3 regulates FRA1 and c-FOS to activate EMT and promote mammary tumorigenesis and metastasis.
Liu X; Bai F; Wang Y; Wang C; Chan HL; Zheng C; Fang J; Zhu WG; Pei XH
Cell Death Dis; 2023 Jun; 14(6):370. PubMed ID: 37353480
[TBL] [Abstract][Full Text] [Related]
13. Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas.
Jolly MK; Somarelli JA; Sheth M; Biddle A; Tripathi SC; Armstrong AJ; Hanash SM; Bapat SA; Rangarajan A; Levine H
Pharmacol Ther; 2019 Feb; 194():161-184. PubMed ID: 30268772
[TBL] [Abstract][Full Text] [Related]
14. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
[TBL] [Abstract][Full Text] [Related]
15. Differential Contributions of Pre- and Post-EMT Tumor Cells in Breast Cancer Metastasis.
Lourenco AR; Ban Y; Crowley MJ; Lee SB; Ramchandani D; Du W; Elemento O; George JT; Jolly MK; Levine H; Sheng J; Wong ST; Altorki NK; Gao D
Cancer Res; 2020 Jan; 80(2):163-169. PubMed ID: 31704888
[TBL] [Abstract][Full Text] [Related]
16. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.
Yoshida T; Ozawa Y; Kimura T; Sato Y; Kuznetsov G; Xu S; Uesugi M; Agoulnik S; Taylor N; Funahashi Y; Matsui J
Br J Cancer; 2014 Mar; 110(6):1497-505. PubMed ID: 24569463
[TBL] [Abstract][Full Text] [Related]
17. Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype.
Hiew MSY; Cheng HP; Huang CJ; Chong KY; Cheong SK; Choo KB; Kamarul T
J Biomed Sci; 2018 Jul; 25(1):57. PubMed ID: 30025541
[TBL] [Abstract][Full Text] [Related]
18. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
19. Multi-modal transcriptomic analysis unravels enrichment of hybrid epithelial/mesenchymal state and enhanced phenotypic heterogeneity in basal breast cancer.
Sahoo S; Ramu S; Nair MG; Pillai M; San Juan BP; Milioli HZ; Mandal S; Naidu CM; Mavatkar AD; Subramaniam H; Neogi AG; Chaffer CL; Prabhu JS; Somarelli JA; Jolly MK
bioRxiv; 2023 Oct; ():. PubMed ID: 37873432
[TBL] [Abstract][Full Text] [Related]
20. Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis.
Garg M
Expert Rev Mol Med; 2017 Mar; 19():e3. PubMed ID: 28322181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
